TA-35, IL00BIDX1428

TA-35 falls 1.55% to 3,975.40 as Tel Aviv session ends

Published on 11/16/2026 at 18:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The TA-35 fell 1.55% to 3,975.40 points as Monday's Tel Aviv session ended. Tower Semiconductor and Nova were among the weakest index constituents, while Teva moved higher.

Tel Aviv stocks end lower

  • The TA-35 closed at 3,975.40 points on November 16, 2026.
  • The index fell 1.55%, or 62.62 points, from the November 13 close of 4,038.02.
  • Tower Semiconductor, Nova and Mizrahi Tefahot were among the largest decliners, while Teva gained.
TA-35, IL00BIDX1428, Illustration mit AI erstellt.

The TA-35 ended Monday's Tel Aviv session at 3,975.40 points, down 1.55% from the previous trading session. The decline amounted to 62.62 points from the November 13 close of 4,038.02. The figures are reported on the Tel Aviv Stock Exchange website.

Key data: The index opened at 4,016.85 points and traded between a high of 4,030.99 and a low of 3,966.93. Turnover in the index securities amounted to ILS 3.0946 billion, according to the exchange's end-of-day figures.

Technology shares weigh on index

Among the most active TA-35 constituents, Tower Semiconductor fell 12.24% and Nova declined 6.35%. Mizrahi Tefahot lost 2.75%, while Israel Discount Bank fell 2.48% and Elbit Systems declined 1.97%. These moves came against a mixed performance among the benchmark's large constituents.

Teva rose 0.86%, making it one of the notable positive contributors among the securities listed in the exchange's end-of-day overview. Bank Hapoalim fell 0.47%, Bank Leumi declined 0.24%, and Phoenix Financial was unchanged. The exchange listed Enlight Energy down 0.23% in the same table.

Index remains concentrated in key sectors

The TA-35's sector classification at the end of the session showed high-tech companies accounting for 40.64% of the index, finance for 40.43% and real-economy companies for 18.94%. The close therefore reflected a session in which weakness among selected technology and financial names outweighed gains in parts of the pharmaceutical and broader market complex.

The index's market capitalization was listed at ILS 2,024,166 million as of November 16. The monthly performance stood at a 2.06% decline, while the year-to-date performance remained positive at 9.47%, based on the exchange's displayed index statistics.

More coverage is available on the TA-35 topic page.

Disclaimer...
en | IL00BIDX1428 | TA-35 | boerse | 70522124 | bgmi